 | | Etiology of embolism |
|  | | Arterial vascular disease |
|
 | | Leading Causes of Mortality and Burden of Disease Worldwide |
|  | | Global projections for selected causes, 2004 to 2030 |
|
 | | Red alert for women’s heart |
|  | | Arterial and Venous Thrombosis |
|
 | | Atherosclerotic Plaque Progression |
|  | | Coagulation and the arterial vessel wall |
|
 | | Thrombus age after thrombosuction |
|  | | Histological spectrum of thrombus and atherosclerotic plaque tissue |
|
 | | IF STAININGS – CO-LOCALIZATION OF TF, FVII & FX |
|  | | EARLY ATHEROSCLEROSIS EXHIBITS AN ENHANCED PRO-COAGULANT STATE |
|
 | | SIGNIFICANTLY HIGHER ETP & TAT IN EARLY ATHEROSCLEROTIC LESIONS |
|  | | Is the level of thrombin generated in blood clinically relevant? |
|
 | | Thrombin being proatherogenic? |
|  | | PHENOTYPIC MODULATION OF THE ARTERIAL VESSEL WALL |
|
 | | Thrombin and atherosclerosis: causality? |
|  | | EXTENSIVE ATHEROSCLEROSIS IN TM Pro/Pro / ApoE-/- CAROTID ARTERIES |
|
 | | INCREASED ACCUMULATION OF MФ AND LESS α-ACTIN AND COLLAGEN I/III IN TM Pro/Pro / ApoE-/- |
|  | | INTRAPLAQUE HEMORRHAGE & PLAQUE RUPTURE IN TM Pro/Pro / ApoE-/- MICE |
|
 | | INTRAPLAQUE HEMORRHAGE & PLAQUE RUPTURE IN MICE |
|  | | ENHANCED NEOANGIOGENESIS IN TM Pro/Pro / ApoE-/- MICE |
|
 | | Clinical manifestations of atheroembolism |
|
|
 | | Treatment? |
|  | | In the coagulation arena: new avenues? |
|
 | | Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization |
|
|
 | | Secondary prevention |
|  | | DABIGATRAN/APC PROTECTS AGAINST SEVERE ATHEROSCLEROSIS PROGRESSION IN TM Pro/Pro / ApoE-/- |
|
 | | ResultsI/R injury : Evans Blue/TTC staining |
|  | | Antithrombotic therapy |
|
Deel deze pagina met collega's en vrienden: